the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis
Neurent Medical has raised €84M across 2 funding rounds from 8 investors, most recently a round in Sep 2026. Based in Galway, Ireland; active in Healthtech. Data as of 21 Sept 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-09-09 | Other | €21M | Claret Capital Partners | View deal → |
| 2026-02-13 | Series C | €63M | Atlantic Bridge,Enterprise Ireland,EQT Life Sciences,Existing investors,Fountain Healthcare Partners,MVM Partners+1 more | View deal → |
